Valuation: Ind-Swift Laboratories Limited

Market Cap 11.4B 119M 104M 97.25M 89.31M 168M 170M 1.16B 451M 5.63B 446M 436M 19.45B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 74.36M 65.37M 60.85M 55.88M 105M 106M 723M 282M 3.52B 279M 273M 12.17B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.72%
Yield 2024 *
-
Yield 2025 -
1 day+5.46%
1 week+3.65%
Current month+17.87%
1 month+19.42%
3 months+74.61%
6 months+118.84%
Current year+172.16%
1 week 217.77
Extreme 217.77
240.7
1 month 197.1
Extreme 197.1
248.45
Current year 87.25
Extreme 87.25
248.45
1 year 87.15
Extreme 87.15
248.45
3 years 68.72
Extreme 68.72
248.45
5 years 52.65
Extreme 52.65
248.45
10 years 15
Extreme 15
248.45
Manager TitleAgeSince
Chief Executive Officer 74 04/01/1995
Chief Executive Officer 43 15/06/2011
Director of Finance/CFO - 29/09/2018
Director TitleAgeSince
Director/Board Member 43 -
Chairman 74 -
Director/Board Member 35 23/03/2010
Date Insider Type Main position Quantity % Market Cap.
9/12/24 A Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+5.46%+3.65%+129.25%+173.40% 205M
+1.68%+2.13%+16.17%+77.49% 48.36B
+1.52%+2.95%+60.39%+112.28% 35.8B
-0.09%-0.66%-8.03%+31.90% 11.83B
-0.05%-3.10%+13.50%+77.95% 11.48B
-0.93%-0.37%+37.53%+142.08% 9.01B
+0.18%+0.58%+49.62%-9.13% 6.99B
+0.95%-1.59%+12.34%+32.81% 6.7B
+0.18%-1.77%+2.36%+172.36% 6.42B
+3.51%-10.57%-31.55%+0.09% 5.3B
Average +1.24%-1.26%+28.16%+81.12% 14.21B
Weighted average by Cap. +1.08%-0.15%+25.66%+81.77%

Financials

2024 2025
Net sales 12.97B 135M 119M 111M 102M 191M 193M 1.32B 514M 6.41B 508M 497M 22.14B 5.62B 58.57M 51.49M 47.93M 44.02M 82.66M 83.75M 570M 223M 2.77B 220M 215M 9.59B
Net income 4.21B 43.9M 38.59M 35.92M 32.99M 61.95M 62.76M 427M 167M 2.08B 165M 161M 7.18B 2.5B 26.12M 22.96M 21.37M 19.63M 36.86M 37.34M 254M 99.23M 1.24B 98.05M 95.93M 4.27B
Net Debt -4.15B -43.31M -38.07M -35.44M -32.55M -61.11M -61.92M -421M -165M -2.05B -163M -159M -7.09B -4.27B -44.48M -39.1M -36.4M -33.43M -62.77M -63.6M -433M -169M -2.11B -167M -163M -7.28B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
27/07/26 239.91 +5.46% 478,681
24/07/26 ₹227.49 +0.66% 447,383
23/07/26 ₹225.99 -3.04% 397,859
22/07/26 ₹233.07 -1.91% 447,639
21/07/26 ₹237.60 +1.54% 271,232
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock